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CASE REPORT
Angiosarcoma of the scalp diagnosed by the presence of
neck inflammation: a case report
Rei Karube1, Hiroyoshi Sasaki1, Keiji Shinozuka1, Yasuhiro Fujisawa2, Toru Yanagawa1, Kenji Yamagata1,
Kojiro Onizawa1, Fujio Otsuka2 and Hiroki Bukawa1
Angiosarcoma is an uncommon malignancy, which spread out from the endothelial cells of vessels. Scalp angiosarcoma with cervical
lymph node metastasis is particularly rare. This article describes a rare case of angiosarcoma of the scalp, presenting as neck
inflammation. Imaging procedures such as computed tomography (CT), magnetic resonance image (MRI) and ultrasonography (US)
were not sufficient to diagnose this case. A needle biopsy provided an effective and accurate diagnosis of cervical lymph node
metastasis. Additional observation and physical examination was required to diagnose the origin of the primary cancerous lesion. Once
the angiosarcoma diagnosis was confirmed histologically, sequential weekly and monthly docetaxel (DTX) treatment was effective in
preventing reoccurrence. Nonetheless, the optimization of angiosarcoma treatment remains a future goal. Although patients generally
describe pain and swelling at the primary lesion site, this patient complained only of painful neck inflammation, without any indication
of pain or swelling of the scalp. A revised diagnostic protocol should note that cervical lymphnodemetastasis of unknownprimary origin
may result from angiosarcoma of the scalp.
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INTRODUCTION
Angiosarcoma is a rare malignant tumor, accounting for only 1%–
5% of all soft tissue sarcomas.1–2 Cutaneous angiosarcoma is the
most common presentation of this neoplasm, which affects the facial
skin and scalp regions.3 Head and neck angiosarcoma is usually seen
in patients older than 60 years of age, and slightly more often in
males.1,3–4 The pathology usually follows an aggressive course, with
progressive local invasion and early metastasis.3 We describe a case of
angiosarcoma of the scalp, presenting as neck inflammation. A needle
biopsy provided an effective and accurate diagnosis of cervical lymph
node metastasis. Additional observation and physical examination
was required to diagnose the origin of the primary cancerous lesion.
Once the angiosarcoma diagnosis was confirmed histologically,
sequential weekly and monthly docetaxel (DTX) treatment was effec-
tive in preventing reoccurrence. Nonetheless, the optimization of
angiosarcoma treatment remains a future goal.
CASE REPORT
A 69-year-old man presented with swelling in the left cervical region
that had persisted for 3 months. He had had a gastric ulcer, but no
significant family history of cancer. A physical examination revealed a
reddish, stiff swelling with tenderness from the left submandibular to
the parotid-masseter region (Figure 1). An oral examination did not
provide any diagnostically relevant details. The laboratory data at the
first visit showed that white blood cell count and C-reactive protein
were 6.03103 mL21 and 0.09 mg?dL21, respectively, and the other
laboratory data was also within normal limit, so the general inflam-
mation was excluded. However, four symptoms of inflammation such
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Figure 1 Pre-treatment view reveals a reddish swelling from the left subman-
dibular to the parotid-masseter region (white arrows).
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as heat, redness, pain and swelling were observed in the left neck,
indicating that mild local inflammation. A computed tomography
(CT) scan showed that the subcutaneous legion (25 mm319 mm3
10 mm) was slightly swollen with an enhancement and expanded
outward with a swollen, round, ring-enhanced lymph node in the left
cervical region (Figure 2a). A magnetic resonance image (MRI)
revealed a high-signal lesion on T2-weighted images under the left
parotid gland (Figure 2b). An 18F-fluorodeoxyglucose positron emis-
sion tomography (PET) CT scan image showed focal uptake in the left
cervical region (Figure 2c and 2d). Ultrasonography (US) showed a
heterogeneous lesion in the cervical region, and gastrointestinal endo-
scopy revealed atrophic gastritis with no sign of a tumor (data not
shown). These examinations indicated a cervical lymph node meta-
stasis but did not detect the primary lesion.
An echo-guided needle biopsy of the neck mass was carried out
to identify the primary tumor. Pathology results (hematoxylin and
eosin staining) indicated atypical, enlarged pleomorphic endothelial
cells and microcyst formation (Figure 3a). Immunohistochemistry
revealed that the tumor cells were positive for CD31, a marker for
immature endothelial cells (Figure 3b), and negative for factor VIII-
related antigen, Keratin, S-100 and Desmin (data not shown). The
pathological and immunohistochemical results pointed to a diagnosis
of angiosarcoma. Although the patient only complained of a painful
neck swelling, a detailed examination revealed that the primary tumor
was angiosarcoma of the scalp. Although the patient experienced an
itchy scalp, he was unaware of a 45 mm330 mm crusty ulcer on the
vertex of his head (Figure 4). Consulting dermatologists confirmed a
final diagnosis of angiosarcoma of the scalp with left cervical lymph
node metastasis (T1bN1M0, stage IV). The specialists in dermatology
diagnosed the vertex lesion as angiosarcoma by the clinical findings
and course, because the treatment for this angiosarcoma was needed
to start as soon as possible and visual examination was enough for
the specialists to diagnose. Further therapy was conducted by them.
The dermatologists administered concurrent treatments of chemo-
therapy (weekly DTX; 25 mg?m22, six treatments, 258 mg total) and
radiotherapy (70 Gy), which led to a decrease in the cervical swelling
and reduced the tumor to 47% of its original volume. Additional
biweekly, outpatient treatment with DTX (15 treatments, 645 mg
total), caused the primary tumor and the cervical metastasis to disap-
pear, although the scalp ulceration remained. A biopsy of the ulcer
revealed no residual malignant cells. Resection of the ulcer lesion was
performed and showed only the scar tissue. Six months later, the
Figure 2 Radiological findings of the cervical lesion. (a) CT scanning image showing a round, swollen, ring-enhanced lymph node in the left cervical region. (b) MRI
revealing a high-signal lesion on T2-weighted images under the left parotid gland. (c and d) PET CT scan image showing focal uptake in the left cervical region. (c) Axial
view. (d) Whole-body view. CT, computed tomography; MRI, magnetic resonance image; PET, positron emission tomography.
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lymph node metastasis in front of the left auricle reappeared. Radio-
therapy (70 Gy) was performed to treat the preauricular lymph node
metastasis, followed by biweekly doxorubicin treatments (20mg?m22,
three times). Approximately 2 years after the final ulcer resection, the
patient appears free of local recurrence and lung metastasis.
DISCUSSION
Angiosarcoma is a rare malignant tumor derived from vascular
endothelial cells that usually follows an aggressive course, marked by
local invasion and early lung metastasis.3,5 The occurrence of this
neoplasm in the oral cavity is extremely rare.1,6–7We describe a patient
with an angiosarcoma of the scalp that was detected initially by a
patient’s complaint of neck swelling and tenderness. Although reports
indicate that cancers of unknown primary origin can be diagnosed
by cervical lymphnode metastasis,8–10 this is the first case report in
which angiosarcoma of the scalp was diagnosed in this manner.
Although patients generally describe pain and swelling at the pri-
mary lesion site, this patient complained only of painful neck inflam-
mation, without any indication of pain or swelling of the scalp.
Imaging procedures such as CT, MRI and US were not sufficient to
diagnose this case. Ordinary in our institution, the vertex site is out of
area in scanning CT or MRI for neck lesions. A retrospective exami-
nation of the PET CT scan indicated an uptake in the vertex of the
head, but the scalp lesion was barely visible (Figure 2d). In actually
radiologists did neither detect the primary lesion. It will be important
that we have to consider a possibility of an existence of the vertex lesion
in such case. The whole-body PET CT indicated a left cervical lymph-
node metastasis. More careful observation and physical examination
was necessary in this case to identify the primary cancer. A revised
diagnostic protocol should note that cervical lymph nodemetastasis of
unknown primary origin may result from angiosarcoma of the scalp.
In addition, an echo-guided needle biopsy was an effective way to
diagnose the lymph node metastasis, which has been reported for
other angiosarcomas as well.11
Patient prognosis for angiosarcoma indicates a median survival
rate of 16 months and cumulative survival rates at 2 and 5 years of
31% and 8%, respectively.12 Although the optimal treatment remains
uncertain, a few reports indicate an extended period of remission or
complete remission following sequential weekly and monthly DTX
treatments.3,13–14 Here we report that the concurrent chemora-
diotherapy (weekly DTX and radiotherapy) and biweekly DTX in
outpatient clinic was effective. Over half of angiosarcoma patients
ultimately develop metastases, particularly to the lung.15 However,
in the present case report, there is no evidence of recurrence 3 years
after the first medical examination. Thus, DTX prove to be an effective
first-line therapy for angiosarcoma.
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Figure 4 Clinical appearance of the vertex of head.
Figure 3 Histological and immunohistochemical aspects. (a) Histological features of the neck tumor showing enlarged pleomorphic endothelial cells andmicrocysts
(hematoxylin and eosin staining, 3400). (b) Immunohistochemical staining showing CD31-positive tumor cells (3400).
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